2Jena B P. Insights on membrane fusion[J]. Cell Biology International, 2000,24 (11):769-771.
3Hayashi T, Tanaka J. Immunogenicity and therapeutic effacacy of Dendrentic-tumor hybrid cells generated by electrofusion[J] .Clinical Immunology, 2002,104(1):14-20.
4Trefzer U, Weingart G, Chen Y W,et al.Hybrid cell vaccination for cancer immune therapyfirst clinical trial with metastatic melanoma [J]. Int J Cancer ,2000,85:618.
5Steinman R M, Turley S, Mellman I, et al.The induction of tolerance bydendritic cells that have captured apoptotic cells[J]. Exp Med ,2000,191:411.
6Song W, Tong Y, Carpenter H, et al.Persistent, antigen-specific, therapeutic antitumor immunityby dendritic cells geneticallymodified with an adenoviral vector to express a model tumor antigen[J]. Gene Ther, 2000,(7):2080.
7Nestle F O. Dendritic cell vaccination for cancer therapy[J]. Oncogene,2000,19:6673.
8Nair S K, Heiser A, Boczkowski D, et al. Induction of cytotoxic T cell responses and tumor immunityagainst unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells[J].Nat Med,2002,(6):1011.
9kugler A,Stuhler G.Rrgression of human metastatic tenal cell carcinoma after vaccinated with tumor cell-dendritic cell hybrids[J].Nat Med,2000,6:332.
10Holmes L M, Li J.A rapid,novel strategy to induce rumor cell specific cytotoxic T lymphocyte(CTL)responses using instant dendritomas[J].J Immunother,2001,(6):332.
